Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine

Introduction: There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns. Results: Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric research 2012-03, Vol.71 (3), p.241-246
Hauptverfasser: Manouchehri, Namdar, Bigam, David L., Churchill, Thomas, Joynt, Chloe, Vento, Maximo, Cheung, Po-Yin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 246
container_issue 3
container_start_page 241
container_title Pediatric research
container_volume 71
creator Manouchehri, Namdar
Bigam, David L.
Churchill, Thomas
Joynt, Chloe
Vento, Maximo
Cheung, Po-Yin
description Introduction: There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns. Results: Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressure (MAP). The hemodynamics deteriorated gradually after initial recovery upon reoxygenation. Heart rate and CI improved with milrinone (D+M) and levosimendan (D+L) administration ( P < 0.05 vs. control). Both regimens improved carotid arterial flow and carotid vascular resistance; D+M additionally improved superior mesentric arterial flow (all P < 0.05 vs. control). No effect was found on renal arterial flow or elevated lactate state with either regimen. D+M piglets also had a lower myocardial oxidized/reduced glutathione ratio ( P < 0.05 vs. control). Discussion: In conclusion, adding milrinone or levosimendan to dopamine similarly improved systemic hemodynamics in H-R newborn piglets. Milrinone also improved mesenteric perfusion and attenuated myocardial oxidative stress. Methods: Twenty-eight piglets (1–4 d, 1.5–2.5 kg) were instrumented for continuous monitoring of systemic MAP and pulmonary arterial pressure (PAP), CI, and carotid, superior mesenteric, and renal arterial flows. Piglets were randomized with blinding to sham-operated, H-R control (saline), and H-R dopamine (10 μg/kg/min) with D+M or D+L groups. H-R piglets underwent H-R followed by 2 h of drug infusion after reoxygenation. Tissue was collected for biochemical/oxidative stress testing and histological analysis.
doi_str_mv 10.1038/pr.2011.48
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4972574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22337258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-c315db2be227e687a2773236ac8c206264b8348048c63bd07b6436c5c11f354d3</originalsourceid><addsrcrecordid>eNptkU1P3DAQhq0KVBbaS39A5UsvRdn6K4n3UqlCfElUvbRny3Emu0aJHY2zLHvgv2NYoCBxssbzzPtq3iHkC2dzzqT-MeJcMM7nSn8gM15KVjCl6j0yY0zyQi4W-oAcpnTNGFelVh_JgRBS1qLUM3L32_foQwxAfaIjQgeI0NIp0h5uYvIDhNYG2kWkAyQIE6B3dATs1snHQH2gq-0Yb70tEOLtdgnBTlkgwKaJGOjolz1MiU4Ij_8bP61oG0c7-ACfyH5n-wSfn94j8u_s9O_JRXH15_zy5NdV4ZSSU-EkL9tGNCBEDZWurahrKWRlnXaCVaJSjZZKM6VdJZuW1U2lZOVKx3knS9XKI_JzpzuumwFal9dA25sR_WBxa6L15m0n-JVZxhujFjmmWmWB7zsBhzGlnNLLLGfm4Qi5Ng9HMEpn-Otrtxf0OfUMfHsCbHK279AG59N_rqwY27ke77iUW2EJaK7jGkNO6j3be6h4obA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Manouchehri, Namdar ; Bigam, David L. ; Churchill, Thomas ; Joynt, Chloe ; Vento, Maximo ; Cheung, Po-Yin</creator><creatorcontrib>Manouchehri, Namdar ; Bigam, David L. ; Churchill, Thomas ; Joynt, Chloe ; Vento, Maximo ; Cheung, Po-Yin</creatorcontrib><description>Introduction: There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns. Results: Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressure (MAP). The hemodynamics deteriorated gradually after initial recovery upon reoxygenation. Heart rate and CI improved with milrinone (D+M) and levosimendan (D+L) administration ( P &lt; 0.05 vs. control). Both regimens improved carotid arterial flow and carotid vascular resistance; D+M additionally improved superior mesentric arterial flow (all P &lt; 0.05 vs. control). No effect was found on renal arterial flow or elevated lactate state with either regimen. D+M piglets also had a lower myocardial oxidized/reduced glutathione ratio ( P &lt; 0.05 vs. control). Discussion: In conclusion, adding milrinone or levosimendan to dopamine similarly improved systemic hemodynamics in H-R newborn piglets. Milrinone also improved mesenteric perfusion and attenuated myocardial oxidative stress. Methods: Twenty-eight piglets (1–4 d, 1.5–2.5 kg) were instrumented for continuous monitoring of systemic MAP and pulmonary arterial pressure (PAP), CI, and carotid, superior mesenteric, and renal arterial flows. Piglets were randomized with blinding to sham-operated, H-R control (saline), and H-R dopamine (10 μg/kg/min) with D+M or D+L groups. H-R piglets underwent H-R followed by 2 h of drug infusion after reoxygenation. Tissue was collected for biochemical/oxidative stress testing and histological analysis.</description><identifier>ISSN: 0031-3998</identifier><identifier>EISSN: 1530-0447</identifier><identifier>DOI: 10.1038/pr.2011.48</identifier><identifier>PMID: 22337258</identifier><identifier>CODEN: PEREBL</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>631/92/436 ; 692/699/75 ; Animals ; Animals, Newborn - physiology ; Biological and medical sciences ; Cardiotonic Agents - pharmacology ; Cardiotonic Agents - therapeutic use ; Dopamine - pharmacology ; Dopamine - therapeutic use ; Drug Therapy, Combination ; General aspects ; Hemodynamics - drug effects ; Hemodynamics - physiology ; Hydrazones - pharmacology ; Hydrazones - therapeutic use ; Hypoxia - drug therapy ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Mesenteric Arteries - drug effects ; Milrinone - pharmacology ; Milrinone - therapeutic use ; Models, Animal ; Myocardial Reperfusion - methods ; Myocardial Reperfusion Injury - prevention &amp; control ; Oxidative Stress - drug effects ; Oxidative Stress - physiology ; Pediatric Surgery ; Pediatrics ; Pyridazines - pharmacology ; Pyridazines - therapeutic use ; Swine ; translational-investigation ; Vasodilator Agents - pharmacology ; Vasodilator Agents - therapeutic use</subject><ispartof>Pediatric research, 2012-03, Vol.71 (3), p.241-246</ispartof><rights>International Pediatric Research Foundation, Inc. 2012</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-c315db2be227e687a2773236ac8c206264b8348048c63bd07b6436c5c11f354d3</citedby><cites>FETCH-LOGICAL-c443t-c315db2be227e687a2773236ac8c206264b8348048c63bd07b6436c5c11f354d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/pr.2011.48$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/pr.2011.48$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25600574$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22337258$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Manouchehri, Namdar</creatorcontrib><creatorcontrib>Bigam, David L.</creatorcontrib><creatorcontrib>Churchill, Thomas</creatorcontrib><creatorcontrib>Joynt, Chloe</creatorcontrib><creatorcontrib>Vento, Maximo</creatorcontrib><creatorcontrib>Cheung, Po-Yin</creatorcontrib><title>Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine</title><title>Pediatric research</title><addtitle>Pediatr Res</addtitle><addtitle>Pediatr Res</addtitle><description>Introduction: There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns. Results: Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressure (MAP). The hemodynamics deteriorated gradually after initial recovery upon reoxygenation. Heart rate and CI improved with milrinone (D+M) and levosimendan (D+L) administration ( P &lt; 0.05 vs. control). Both regimens improved carotid arterial flow and carotid vascular resistance; D+M additionally improved superior mesentric arterial flow (all P &lt; 0.05 vs. control). No effect was found on renal arterial flow or elevated lactate state with either regimen. D+M piglets also had a lower myocardial oxidized/reduced glutathione ratio ( P &lt; 0.05 vs. control). Discussion: In conclusion, adding milrinone or levosimendan to dopamine similarly improved systemic hemodynamics in H-R newborn piglets. Milrinone also improved mesenteric perfusion and attenuated myocardial oxidative stress. Methods: Twenty-eight piglets (1–4 d, 1.5–2.5 kg) were instrumented for continuous monitoring of systemic MAP and pulmonary arterial pressure (PAP), CI, and carotid, superior mesenteric, and renal arterial flows. Piglets were randomized with blinding to sham-operated, H-R control (saline), and H-R dopamine (10 μg/kg/min) with D+M or D+L groups. H-R piglets underwent H-R followed by 2 h of drug infusion after reoxygenation. Tissue was collected for biochemical/oxidative stress testing and histological analysis.</description><subject>631/92/436</subject><subject>692/699/75</subject><subject>Animals</subject><subject>Animals, Newborn - physiology</subject><subject>Biological and medical sciences</subject><subject>Cardiotonic Agents - pharmacology</subject><subject>Cardiotonic Agents - therapeutic use</subject><subject>Dopamine - pharmacology</subject><subject>Dopamine - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>General aspects</subject><subject>Hemodynamics - drug effects</subject><subject>Hemodynamics - physiology</subject><subject>Hydrazones - pharmacology</subject><subject>Hydrazones - therapeutic use</subject><subject>Hypoxia - drug therapy</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mesenteric Arteries - drug effects</subject><subject>Milrinone - pharmacology</subject><subject>Milrinone - therapeutic use</subject><subject>Models, Animal</subject><subject>Myocardial Reperfusion - methods</subject><subject>Myocardial Reperfusion Injury - prevention &amp; control</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - physiology</subject><subject>Pediatric Surgery</subject><subject>Pediatrics</subject><subject>Pyridazines - pharmacology</subject><subject>Pyridazines - therapeutic use</subject><subject>Swine</subject><subject>translational-investigation</subject><subject>Vasodilator Agents - pharmacology</subject><subject>Vasodilator Agents - therapeutic use</subject><issn>0031-3998</issn><issn>1530-0447</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkU1P3DAQhq0KVBbaS39A5UsvRdn6K4n3UqlCfElUvbRny3Emu0aJHY2zLHvgv2NYoCBxssbzzPtq3iHkC2dzzqT-MeJcMM7nSn8gM15KVjCl6j0yY0zyQi4W-oAcpnTNGFelVh_JgRBS1qLUM3L32_foQwxAfaIjQgeI0NIp0h5uYvIDhNYG2kWkAyQIE6B3dATs1snHQH2gq-0Yb70tEOLtdgnBTlkgwKaJGOjolz1MiU4Ij_8bP61oG0c7-ACfyH5n-wSfn94j8u_s9O_JRXH15_zy5NdV4ZSSU-EkL9tGNCBEDZWurahrKWRlnXaCVaJSjZZKM6VdJZuW1U2lZOVKx3knS9XKI_JzpzuumwFal9dA25sR_WBxa6L15m0n-JVZxhujFjmmWmWB7zsBhzGlnNLLLGfm4Qi5Ng9HMEpn-Otrtxf0OfUMfHsCbHK279AG59N_rqwY27ke77iUW2EJaK7jGkNO6j3be6h4obA</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Manouchehri, Namdar</creator><creator>Bigam, David L.</creator><creator>Churchill, Thomas</creator><creator>Joynt, Chloe</creator><creator>Vento, Maximo</creator><creator>Cheung, Po-Yin</creator><general>Nature Publishing Group US</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20120301</creationdate><title>Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine</title><author>Manouchehri, Namdar ; Bigam, David L. ; Churchill, Thomas ; Joynt, Chloe ; Vento, Maximo ; Cheung, Po-Yin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-c315db2be227e687a2773236ac8c206264b8348048c63bd07b6436c5c11f354d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>631/92/436</topic><topic>692/699/75</topic><topic>Animals</topic><topic>Animals, Newborn - physiology</topic><topic>Biological and medical sciences</topic><topic>Cardiotonic Agents - pharmacology</topic><topic>Cardiotonic Agents - therapeutic use</topic><topic>Dopamine - pharmacology</topic><topic>Dopamine - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>General aspects</topic><topic>Hemodynamics - drug effects</topic><topic>Hemodynamics - physiology</topic><topic>Hydrazones - pharmacology</topic><topic>Hydrazones - therapeutic use</topic><topic>Hypoxia - drug therapy</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mesenteric Arteries - drug effects</topic><topic>Milrinone - pharmacology</topic><topic>Milrinone - therapeutic use</topic><topic>Models, Animal</topic><topic>Myocardial Reperfusion - methods</topic><topic>Myocardial Reperfusion Injury - prevention &amp; control</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - physiology</topic><topic>Pediatric Surgery</topic><topic>Pediatrics</topic><topic>Pyridazines - pharmacology</topic><topic>Pyridazines - therapeutic use</topic><topic>Swine</topic><topic>translational-investigation</topic><topic>Vasodilator Agents - pharmacology</topic><topic>Vasodilator Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manouchehri, Namdar</creatorcontrib><creatorcontrib>Bigam, David L.</creatorcontrib><creatorcontrib>Churchill, Thomas</creatorcontrib><creatorcontrib>Joynt, Chloe</creatorcontrib><creatorcontrib>Vento, Maximo</creatorcontrib><creatorcontrib>Cheung, Po-Yin</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pediatric research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manouchehri, Namdar</au><au>Bigam, David L.</au><au>Churchill, Thomas</au><au>Joynt, Chloe</au><au>Vento, Maximo</au><au>Cheung, Po-Yin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine</atitle><jtitle>Pediatric research</jtitle><stitle>Pediatr Res</stitle><addtitle>Pediatr Res</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>71</volume><issue>3</issue><spage>241</spage><epage>246</epage><pages>241-246</pages><issn>0031-3998</issn><eissn>1530-0447</eissn><coden>PEREBL</coden><abstract>Introduction: There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns. Results: Severely hypoxic piglets had cardiogenic shock with depressed cardiac index (CI) and mean arterial pressure (MAP). The hemodynamics deteriorated gradually after initial recovery upon reoxygenation. Heart rate and CI improved with milrinone (D+M) and levosimendan (D+L) administration ( P &lt; 0.05 vs. control). Both regimens improved carotid arterial flow and carotid vascular resistance; D+M additionally improved superior mesentric arterial flow (all P &lt; 0.05 vs. control). No effect was found on renal arterial flow or elevated lactate state with either regimen. D+M piglets also had a lower myocardial oxidized/reduced glutathione ratio ( P &lt; 0.05 vs. control). Discussion: In conclusion, adding milrinone or levosimendan to dopamine similarly improved systemic hemodynamics in H-R newborn piglets. Milrinone also improved mesenteric perfusion and attenuated myocardial oxidative stress. Methods: Twenty-eight piglets (1–4 d, 1.5–2.5 kg) were instrumented for continuous monitoring of systemic MAP and pulmonary arterial pressure (PAP), CI, and carotid, superior mesenteric, and renal arterial flows. Piglets were randomized with blinding to sham-operated, H-R control (saline), and H-R dopamine (10 μg/kg/min) with D+M or D+L groups. H-R piglets underwent H-R followed by 2 h of drug infusion after reoxygenation. Tissue was collected for biochemical/oxidative stress testing and histological analysis.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>22337258</pmid><doi>10.1038/pr.2011.48</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0031-3998
ispartof Pediatric research, 2012-03, Vol.71 (3), p.241-246
issn 0031-3998
1530-0447
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4972574
source MEDLINE; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects 631/92/436
692/699/75
Animals
Animals, Newborn - physiology
Biological and medical sciences
Cardiotonic Agents - pharmacology
Cardiotonic Agents - therapeutic use
Dopamine - pharmacology
Dopamine - therapeutic use
Drug Therapy, Combination
General aspects
Hemodynamics - drug effects
Hemodynamics - physiology
Hydrazones - pharmacology
Hydrazones - therapeutic use
Hypoxia - drug therapy
Medical sciences
Medicine
Medicine & Public Health
Mesenteric Arteries - drug effects
Milrinone - pharmacology
Milrinone - therapeutic use
Models, Animal
Myocardial Reperfusion - methods
Myocardial Reperfusion Injury - prevention & control
Oxidative Stress - drug effects
Oxidative Stress - physiology
Pediatric Surgery
Pediatrics
Pyridazines - pharmacology
Pyridazines - therapeutic use
Swine
translational-investigation
Vasodilator Agents - pharmacology
Vasodilator Agents - therapeutic use
title Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A51%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Milrinone%20is%20preferred%20to%20levosimendan%20for%20mesenteric%20perfusion%20in%20hypoxia-reoxygenated%20newborn%20piglets%20treated%20with%20dopamine&rft.jtitle=Pediatric%20research&rft.au=Manouchehri,%20Namdar&rft.date=2012-03-01&rft.volume=71&rft.issue=3&rft.spage=241&rft.epage=246&rft.pages=241-246&rft.issn=0031-3998&rft.eissn=1530-0447&rft.coden=PEREBL&rft_id=info:doi/10.1038/pr.2011.48&rft_dat=%3Cpubmed_cross%3E22337258%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22337258&rfr_iscdi=true